Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study

We aimed to evaluate sarcopenia and sarcopenic obesity (SO) in patients with type 2 diabetes mellitus (T2DM), possible relationships with serum irisin and myostatin levels, and the effect of glycemic control on SO. Ninety T2DM patients were included in this a cross-sectional study. Sarcopenia was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Oguz, Ayten, Sahin, Murat, Tuzun, Dilek, Kurutas, Ergul B., Ulgen, Cansu, Bozkus, Ozlem, Gul, Kamile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257893/
https://www.ncbi.nlm.nih.gov/pubmed/34190188
http://dx.doi.org/10.1097/MD.0000000000026529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257893/
https://www.ncbi.nlm.nih.gov/pubmed/34190188
http://dx.doi.org/10.1097/MD.0000000000026529

Ejemplares similares